Arylsulfatase G Inactivation Causes Loss of Heparan Sulfate 3-O-Sulfatase Activity and Mucopolysaccharidosis in Mice

Kowalewski B, Lamanna WC, Lawrence R, Damme M, Padva M, Stroobants S, Kalus I, Frese M-A, Lübke T, Lüllmann-Rauch R, D'Hooge R, et al. (2012)
Proc. Natl. Acad. Sci. USA 109(26): 10310-10315.

Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ; ; ; ; ; ; ; ; ;
All
Publishing Year
ISSN
eISSN
PUB-ID

Cite this

Kowalewski B, Lamanna WC, Lawrence R, et al. Arylsulfatase G Inactivation Causes Loss of Heparan Sulfate 3-O-Sulfatase Activity and Mucopolysaccharidosis in Mice. Proc. Natl. Acad. Sci. USA. 2012;109(26):10310-10315.
Kowalewski, B., Lamanna, W. C., Lawrence, R., Damme, M., Padva, M., Stroobants, S., Kalus, I., et al. (2012). Arylsulfatase G Inactivation Causes Loss of Heparan Sulfate 3-O-Sulfatase Activity and Mucopolysaccharidosis in Mice. Proc. Natl. Acad. Sci. USA, 109(26), 10310-10315.
Kowalewski, B., Lamanna, W. C., Lawrence, R., Damme, M., Padva, M., Stroobants, S., Kalus, I., Frese, M. - A., Lübke, T., Lüllmann-Rauch, R., et al. (2012). Arylsulfatase G Inactivation Causes Loss of Heparan Sulfate 3-O-Sulfatase Activity and Mucopolysaccharidosis in Mice. Proc. Natl. Acad. Sci. USA 109, 10310-10315.
Kowalewski, B., et al., 2012. Arylsulfatase G Inactivation Causes Loss of Heparan Sulfate 3-O-Sulfatase Activity and Mucopolysaccharidosis in Mice. Proc. Natl. Acad. Sci. USA, 109(26), p 10310-10315.
B. Kowalewski, et al., “Arylsulfatase G Inactivation Causes Loss of Heparan Sulfate 3-O-Sulfatase Activity and Mucopolysaccharidosis in Mice”, Proc. Natl. Acad. Sci. USA, vol. 109, 2012, pp. 10310-10315.
Kowalewski, B., Lamanna, W.C., Lawrence, R., Damme, M., Padva, M., Stroobants, S., Kalus, I., Frese, M.-A., Lübke, T., Lüllmann-Rauch, R., D'Hooge, R., Esko, J.D., Dierks, T.: Arylsulfatase G Inactivation Causes Loss of Heparan Sulfate 3-O-Sulfatase Activity and Mucopolysaccharidosis in Mice. Proc. Natl. Acad. Sci. USA. 109, 10310-10315 (2012).
Kowalewski, Björn, Lamanna, William Christopher, Lawrence, Roger, Damme, Markus, Padva, Michael, Stroobants, Stijn, Kalus, Ina, Frese, Marc-André, Lübke, Torben, Lüllmann-Rauch, Renate, D'Hooge, Rudi, Esko, Jeffrey D, and Dierks, Thomas. “Arylsulfatase G Inactivation Causes Loss of Heparan Sulfate 3-O-Sulfatase Activity and Mucopolysaccharidosis in Mice”. Proc. Natl. Acad. Sci. USA 109.26 (2012): 10310-10315.
This data publication is cited in the following publications:
This publication cites the following data publications:

14 Citations in Europe PMC

Data provided by Europe PubMed Central.

Sanfilippo syndrome: causes, consequences, and treatments.
Fedele AO., Appl Clin Genet 8(), 2015
PMID: 26648750
Ataxia is the major neuropathological finding in arylsulfatase G-deficient mice: similarities and dissimilarities to Sanfilippo disease (mucopolysaccharidosis type III).
Kowalewski B, Heimann P, Ortkras T, Lullmann-Rauch R, Sawada T, Walkley SU, Dierks T, Damme M., Hum. Mol. Genet. 24(7), 2015
PMID: 25452429
From bedside to cell biology: a century of history on lysosomal dysfunction.
Coutinho MF, Matos L, Alves S., Gene 555(1), 2015
PMID: 25275857
A rare homozygous MFSD8 single-base-pair deletion and frameshift in the whole genome sequence of a Chinese Crested dog with neuronal ceroid lipofuscinosis.
Guo J, O'Brien DP, Mhlanga-Mutangadura T, Olby NJ, Taylor JF, Schnabel RD, Katz ML, Johnson GS., BMC Vet. Res. 10(), 2014
PMID: 25551667
Development of cerebellar pathology in the canine model of mucopolysaccharidosis type IIIA (MPS IIIA).
Hassiotis S, Jolly RD, Hemsley KM., Mol. Genet. Metab. 113(4), 2014
PMID: 25453402
Molecular characterization of arylsulfatase G: expression, processing, glycosylation, transport, and activity.
Kowalewski B, Lubke T, Kollmann K, Braulke T, Reinheckel T, Dierks T, Damme M., J. Biol. Chem. 289(40), 2014
PMID: 25135642
The laboratory diagnosis of mucopolysaccharidosis III (Sanfilippo syndrome): A changing landscape.
Bodamer OA, Giugliani R, Wood T., Mol. Genet. Metab. 113(1-2), 2014
PMID: 25127543
Hs3st3-modified heparan sulfate controls KIT+ progenitor expansion by regulating 3-O-sulfotransferases.
Patel VN, Lombaert IM, Cowherd SN, Shworak NW, Xu Y, Liu J, Hoffman MP., Dev. Cell 29(6), 2014
PMID: 24960693
Lysosomal diseases: diagnostic update.
Winchester B., J. Inherit. Metab. Dis. 37(4), 2014
PMID: 24711203
Heparan sulfate 3-O-sulfation: a rare modification in search of a function.
Thacker BE, Xu D, Lawrence R, Esko JD., Matrix Biol. 35(), 2014
PMID: 24361527
Genome-wide association study in musician's dystonia: a risk variant at the arylsulfatase G locus?
Lohmann K, Schmidt A, Schillert A, Winkler S, Albanese A, Baas F, Bentivoglio AR, Borngraber F, Bruggemann N, Defazio G, Del Sorbo F, Deuschl G, Edwards MJ, Gasser T, Gomez-Garre P, Graf J, Groen JL, Grunewald A, Hagenah J, Hemmelmann C, Jabusch HC, Kaji R, Kasten M, Kawakami H, Kostic VS, Liguori M, Mir P, Munchau A, Ricchiuti F, Schreiber S, Siegesmund K, Svetel M, Tijssen MA, Valente EM, Westenberger A, Zeuner KE, Zittel S, Altenmuller E, Ziegler A, Klein C., Mov. Disord. 29(7), 2014
PMID: 24375517
Glycan-based biomarkers for mucopolysaccharidoses.
Lawrence R, Brown JR, Lorey F, Dickson PI, Crawford BE, Esko JD., Mol. Genet. Metab. 111(2), 2014
PMID: 23958290
Arylsulfatase K, a novel lysosomal sulfatase.
Wiegmann EM, Westendorf E, Kalus I, Pringle TH, Lubke T, Dierks T., J. Biol. Chem. 288(42), 2013
PMID: 23986440
Molecular characterization of 355 mucopolysaccharidosis patients reveals 104 novel mutations.
Pollard LM, Jones JR, Wood TC., J. Inherit. Metab. Dis. 36(2), 2013
PMID: 22976768

33 References

Data provided by Europe PubMed Central.

Neurocognitive and psychotiform behavioral alterations and enhanced hippocampal long-term potentiation in transgenic mice displaying neuropathological features of human alpha-mannosidosis.
D'Hooge R, Lullmann-Rauch R, Beckers T, Balschun D, Schwake M, Reiss K, von Figura K, Saftig P., J. Neurosci. 25(28), 2005
PMID: 16014715
Molecular characterization and gene disruption of mouse lysosomal putative serine carboxypeptidase 1.
Kollmann K, Damme M, Deuschl F, Kahle J, D'Hooge R, Lullmann-Rauch R, Lubke T., FEBS J. 276(5), 2009
PMID: 19187242
Conversion of cysteine to formylglycine: a protein modification in the endoplasmic reticulum.
Dierks T, Schmidt B, von Figura K., Proc. Natl. Acad. Sci. U.S.A. 94(22), 1997
PMID: 9342345
Turbidimetry of inorganic sulfate, ester sulfate, and total sulfur in urine.
Lundquist P, Martensson J, Sorbo B, Ohman S., Clin. Chem. 26(8), 1980
PMID: 7389089
[Effect of the injection of Triton WR 1339 on the hepatic lysosomes of the rat.]
WATTIAUX R, WIBO M, BAUDHUIN P., Arch. Int. Physiol. Biochim. 71(), 1963
PMID: 13999241
Special considerations for proteoglycans and glycosaminoglycans and their purification
Esko JD., 2001
Evolutionary differences in glycosaminoglycan fine structure detected by quantitative glycan reductive isotope labeling.
Lawrence R, Olson SK, Steele RE, Wang L, Warrior R, Cummings RD, Esko JD., J. Biol. Chem. 283(48), 2008
PMID: 18818196

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 22689975
PubMed | Europe PMC

Search this title in

Google Scholar